Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients.
The study aims to answer the following question:
Does the PPS provide a more accurate prediction of VTE risk?
Participants will:
Have their VTE risk assessed using the PPS during their hospital admission.
Eligibility criteria
Qualifiers
Patients who have undergone preoperative Padua Prediction Score assessment.
Inpatients with a hospital stay over 3 days
Written informed consent obtained from patients or their legal guardians.
Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.
Disqualifiers
Preexisting LEVT or pulmonary embolism.
Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).
receiving any anticoagulation therapy for any reason.
patients who did not undergo a postoperative D-dimer test.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov